Catechins in stroke: multi-target mechanisms, preclinical evidence, and translational challenges
Yue Zhang, Shuangcui Wang, Qingqiang Yuan · 2026
Read Catechins in stroke: multi-target mechanisms, preclinical evidence, and translational challenges by Yue Zhang, Shuangcui Wang, Qingqiang Yuan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624970.txt.
Description
Yue Zhang, Shuangcui Wang, and Qingqiang Yuan review catechins, the plant compounds in tea, as possible protectors after stroke, in a 2026 paper. Stroke is a leading cause of death and disability, and treatment choices remain few. Catechins have shown nerve-guarding effects in many lab studies, which makes them tempting candidates.
The review searched three databases across four decades of work on both major stroke types. In animal and cell studies, catechins eased oxidative damage and inflammation, steered immune cells toward calmer states, and held the blood-brain barrier together. They also curbed cell death and restored a cell clean-up process. The hard part is translation: doses, timing, and delivery in humans are still unproven.
Catalog record
| CREATOR | Yue Zhang, Shuangcui Wang, Qingqiang Yuan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 87 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |